Logo image of DNUT

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

NASDAQ:DNUT - Nasdaq - US50101L1061 - Common Stock - Currency: USD

9.15  -0.12 (-1.29%)

After market: 9.1 -0.05 (-0.55%)

Fundamental Rating

2

Taking everything into account, DNUT scores 2 out of 10 in our fundamental rating. DNUT was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. DNUT may be in some trouble as it scores bad on both profitability and health. DNUT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

DNUT had positive earnings in the past year.
DNUT had a positive operating cash flow in the past year.
In the past 5 years DNUT always reported negative net income.
Each year in the past 5 years DNUT had a positive operating cash flow.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 50M -50M 100M

1.2 Ratios

DNUT's Return On Assets of 0.92% is in line compared to the rest of the industry. DNUT outperforms 40.46% of its industry peers.
DNUT has a Return On Equity of 2.39%. This is comparable to the rest of the industry: DNUT outperforms 53.44% of its industry peers.
DNUT's Return On Invested Capital of 0.02% is on the low side compared to the rest of the industry. DNUT is outperformed by 77.10% of its industry peers.
DNUT had an Average Return On Invested Capital over the past 3 years of 0.99%. This is significantly below the industry average of 10.79%.
Industry RankSector Rank
ROA 0.92%
ROE 2.39%
ROIC 0.02%
ROA(3y)-0.82%
ROA(5y)-1.17%
ROE(3y)-2.19%
ROE(5y)-4.21%
ROIC(3y)0.99%
ROIC(5y)0.87%
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -2 -4 -6 -8

1.3 Margins

With a Profit Margin value of 1.64%, DNUT perfoms like the industry average, outperforming 43.51% of the companies in the same industry.
The Operating Margin of DNUT (0.03%) is worse than 77.10% of its industry peers.
In the last couple of years the Operating Margin of DNUT has declined.
DNUT's Gross Margin of 33.41% is on the low side compared to the rest of the industry. DNUT is outperformed by 73.28% of its industry peers.
DNUT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.03%
PM (TTM) 1.64%
GM 33.41%
OM growth 3Y47.34%
OM growth 5Y-22.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y0.69%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

DNUT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
DNUT has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, DNUT has a worse debt to assets ratio.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that DNUT is in the distress zone and has some risk of bankruptcy.
DNUT has a Altman-Z score of 0.81. This is in the lower half of the industry: DNUT underperforms 70.99% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that DNUT is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.68, DNUT is doing good in the industry, outperforming 67.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z 0.81
ROIC/WACC0
WACC8.92%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.35 indicates that DNUT may have some problems paying its short term obligations.
With a Current ratio value of 0.35, DNUT is not doing good in the industry: 84.73% of the companies in the same industry are doing better.
DNUT has a Quick Ratio of 0.35. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
DNUT's Quick ratio of 0.28 is on the low side compared to the rest of the industry. DNUT is outperformed by 87.02% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.28
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for DNUT have decreased strongly by -33.33% in the last year.
Looking at the last year, DNUT shows a small growth in Revenue. The Revenue has grown by 4.41% in the last year.
Measured over the past years, DNUT shows a quite strong growth in Revenue. The Revenue has been growing by 16.20% on average per year.
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)4.41%
Revenue growth 3Y14.54%
Revenue growth 5Y16.2%
Sales Q2Q%-6.75%

3.2 Future

Based on estimates for the next years, DNUT will show a very strong growth in Earnings Per Share. The EPS will grow by 22.02% on average per year.
The Revenue is expected to grow by 5.60% on average over the next years.
EPS Next Y-26.41%
EPS Next 2Y4.65%
EPS Next 3Y22.02%
EPS Next 5YN/A
Revenue Next Year-0.47%
Revenue Next 2Y2.42%
Revenue Next 3Y5.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DNUT is valuated quite expensively with a Price/Earnings ratio of 45.75.
Compared to the rest of the industry, the Price/Earnings ratio of DNUT is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 29.63, DNUT is valued quite expensively.
With a Price/Forward Earnings ratio of 29.84, DNUT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DNUT is on the same level as its industry peers.
DNUT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 45.75
Fwd PE 29.84
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DNUT is valued a bit more expensive than the industry average as 62.60% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.41
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

A more expensive valuation may be justified as DNUT's earnings are expected to grow with 22.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.65%
EPS Next 3Y22.02%

More info and screens

3

5. Dividend

5.1 Amount

DNUT has a Yearly Dividend Yield of 1.51%.
Compared to an average industry Dividend Yield of 3.08, DNUT pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.27, DNUT is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.
DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

83.85% of the earnings are spent on dividend by DNUT. This is not a sustainable payout ratio.
DP83.85%
EPS Next 2Y4.65%
EPS Next 3Y22.02%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 50M -50M 100M
DNUT Dividend Payout.DNUT Dividend Payout, showing the Payout Ratio.DNUT Dividend Payout.PayoutRetained Earnings

More info and screens

KRISPY KREME INC

NASDAQ:DNUT (2/21/2025, 8:14:15 PM)

After market: 9.1 -0.05 (-0.55%)

9.15

-0.12 (-1.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-25 2025-02-25/bmo
Inst Owners62.51%
Inst Owner Change-90.76%
Ins Owners3.86%
Ins Owner Change-0.06%
Market Cap1.56B
Analysts77.78
Price Target14.9 (62.84%)
Short Float %23.63%
Short Ratio10.47
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP83.85%
Div Incr Years0
Div Non Decr Years3
Ex-Date01-22 2025-01-22 (0.035)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-97.26%
Min EPS beat(2)-192.23%
Max EPS beat(2)-2.29%
EPS beat(4)1
Avg EPS beat(4)-54.04%
Min EPS beat(4)-192.23%
Max EPS beat(4)7.96%
EPS beat(8)4
Avg EPS beat(8)-29.04%
EPS beat(12)5
Avg EPS beat(12)-23.76%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.65%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.21%
Revenue beat(4)1
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)0.71%
Revenue beat(8)3
Avg Revenue beat(8)-0.72%
Revenue beat(12)4
Avg Revenue beat(12)-0.75%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.98%
PT rev (3m)-4.64%
EPS NQ rev (1m)-1.45%
EPS NQ rev (3m)-7.31%
EPS NY rev (1m)-1.22%
EPS NY rev (3m)-12.77%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 45.75
Fwd PE 29.84
P/S 0.91
P/FCF N/A
P/OCF 76.51
P/B 1.32
P/tB N/A
EV/EBITDA 17.41
EPS(TTM)0.2
EY2.19%
EPS(NY)0.31
Fwd EY3.35%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)0.12
OCFY1.31%
SpS10.07
BVpS6.94
TBVpS-4.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.92%
ROE 2.39%
ROCE 0.02%
ROIC 0.02%
ROICexc 0.02%
ROICexgc 0.06%
OM 0.03%
PM (TTM) 1.64%
GM 33.41%
FCFM N/A
ROA(3y)-0.82%
ROA(5y)-1.17%
ROE(3y)-2.19%
ROE(5y)-4.21%
ROIC(3y)0.99%
ROIC(5y)0.87%
ROICexc(3y)1%
ROICexc(5y)0.88%
ROICexgc(3y)4.94%
ROICexgc(5y)4.58%
ROCE(3y)1.25%
ROCE(5y)1.1%
ROICexcg growth 3Y49.87%
ROICexcg growth 5YN/A
ROICexc growth 3Y65.5%
ROICexc growth 5YN/A
OM growth 3Y47.34%
OM growth 5Y-22.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.28%
GM growth 5Y0.69%
F-Score7
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA 5.88
Cap/Depr 87.79%
Cap/Sales 6.99%
Interest Coverage 250
Cash Conversion 14.86%
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.28
Altman-Z 0.81
F-Score7
WACC8.92%
ROIC/WACC0
Cap/Depr(3y)105.11%
Cap/Depr(5y)111.35%
Cap/Sales(3y)7.71%
Cap/Sales(5y)7.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-26.41%
EPS Next 2Y4.65%
EPS Next 3Y22.02%
EPS Next 5YN/A
Revenue 1Y (TTM)4.41%
Revenue growth 3Y14.54%
Revenue growth 5Y16.2%
Sales Q2Q%-6.75%
Revenue Next Year-0.47%
Revenue Next 2Y2.42%
Revenue Next 3Y5.6%
Revenue Next 5YN/A
EBIT growth 1Y-96.21%
EBIT growth 3Y68.76%
EBIT growth 5Y-9.69%
EBIT Next Year156.91%
EBIT Next 3Y51.83%
EBIT Next 5YN/A
FCF growth 1Y-4832.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.02%
OCF growth 3Y16.64%
OCF growth 5Y-21.03%